The World Health Organization (WHO) on Monday issued its first-ever global guidelines on the use of GLP-1 medications for treating obesity as a chronic illness. In a press release, the WHO said this guidance aimed to help reduce the “skyrocketing health costs” associated with obesity, which are projected to have a global economic cost of…
You may also like
Trump admin will reconsider part of rule to protect miners from lung diseases
The Trump administration says it will reconsider aspects of a rule that aims to protect ...
RFK Jr. replaces chair of controversial vaccine advisory panel
The chair of a federal vaccine advisory committee, himself a well-known vaccine critic, will be ...